RhumbLine Advisers’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $430K | Buy |
|
|||||
|
2025
Q1 | $348K | Sell |
|
|||||
|
2024
Q4 | $435K | Sell |
|
|||||
|
2024
Q3 | $446K | Sell |
|
|||||
|
2024
Q2 | $455K | Sell |
|
|||||
|
2024
Q1 | $573K | Sell |
|
|||||
|
2023
Q4 | $449K | Buy |
|
|||||
|
2023
Q3 | $403K | Sell |
|
|||||
|
2023
Q2 | $528K | Buy |
|
|||||
|
2023
Q1 | $414K | Buy |
|
|||||
|
2022
Q4 | $568K | Buy |
|
|||||
|
2022
Q3 | $661K | Buy |
|
|||||
|
2022
Q2 | $779K | Buy |
|
|||||
|
2022
Q1 | $594K | Sell |
|
|||||
|
2021
Q4 | $771K | Buy |
|
|||||
|
2021
Q3 | $3M | Buy |
|
|||||
|
2021
Q2 | $1.76M | Buy |
|
|||||
|
2021
Q1 | $1.06M | Buy |
|
|||||
|
2020
Q4 | $523K | Buy |
|